RBC Capital Maintains Outperform on Verastem, Lowers Price Target to $12

Benzinga · 06/25 14:38
RBC Capital analyst Leonid Timashev maintains Verastem (NASDAQ:VSTM) with a Outperform and lowers the price target from $16 to $12.